Simplex Trading
GNMX

Simplex Trading’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Simplex Trading’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed – – 8692
2019
Q4 		$0 Buy
+100
New +$14 ﹤0.01% 8363
2019
Q1 		– Sell
-1,671
Closed -$1K – 8261
2018
Q4 		$1K Sell
1,671
-2,320
-58% -$2.59K ﹤0.01% 6858
2018
Q3 		$4K Buy
3,991
+3,970
+18,905% +$4.44K ﹤0.01% 6908
2018
Q2 		$0 Buy
+21
New +$32 ﹤0.01% 8175
2018
Q1 		– Sell
-29
Closed -$54 – 7278
2017
Q4 		$0 Sell
29
-200
-87% -$273 ﹤0.01% 7078
2017
Q3 		$0 Buy
+229
New +$293 ﹤0.01% 7035
2017
Q2 		– Sell
-300
Closed -$434 – 7177
2017
Q1 		$0 Sell
300
-408
-58% -$1.85K ﹤0.01% 7119
2016
Q4 		$3K Buy
708
+179
+34% +$942 ﹤0.01% 4890
2016
Q3 		$2K Buy
+529
New +$3.02K ﹤0.01% 5132
2016
Q2 		– Sell
-1,274
Closed -$6.69K – 6763
2016
Q1 		$5K Sell
1,274
-1,291
-50% -$5.31K ﹤0.01% 4166
2015
Q4 		$15K Buy
+2,565
New +$17.4K ﹤0.01% 2983
2015
Q1 		– Sell
-165
Closed -$1.25K – 5918
2014
Q4 		$1K Buy
+165
New +$815 ﹤0.01% 4410

Simplex Trading's GNMX Position: Q1 2020 in Review

Simplex Trading sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 100 shares.

Simplex Trading first reported a position in GNMX in Q4 2014 and held it in 12 quarters. The position peaked at $15K in Q4 2015. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.

  • Simplex Trading reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
  • Simplex Trading sold 100 Aevi Genomic Medicine Inc shares in Q1 2020.
  • Simplex Trading first reported a position in Aevi Genomic Medicine Inc in Q4 2014 and held it in 12 quarters.
  • Simplex Trading's Aevi Genomic Medicine Inc position peaked at $15K in Q4 2015.
  • 2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.